Become a student member today for free and be part of the RACGP community
2021.1 RCE and 2021.2 AKT results release on 1 September and 2021.2 KFP results release on 30 September 2021.
Practice Experience Program is a self-directed education program designed to support non vocationally registered doctors on their pathway to RACGP Fellowship
RACGP offer courses and events to further develop the knowledge you need to develop your GP career
Discover a world of educational opportunities to support your lifelong learning
Become a provider with the CPD Program and be recognised for the quality education and training you offer GPs
The Diabetes Handbook provides the general practice team with updated guidance and recommendations for managing type 2 diabetes
Stay up-to-date with the latest information and resources on the COVID-19 vaccine rollout.
Coronavirus is an evolving international health concern. Stay informed with the latest information.
Download the Standards for general practice (5th edition) - a benchmark for quality care and risk management in Australian general practices
Coronavirus (COVID-19) resources for general practitioners
Advice and guidelines for GPs and practice teams to help protect general practice information systems
Video consultations can provide convenient and accessible healthcare delivery
Read all of the RACGP reports and submissions on various healthcare topics
Read all of the RACGP position statements on various healthcare topics
Join our RACGP Facebook groups
Guideline for the management of knee and hip osteoarthritis
We suggest not offering therapeutic ultrasound for people with knee and/or hip osteoarthritis (OA).
Conditional against recommendation
Therapeutic ultrasound is the application of high-frequency sound waves to soft tissues via a treatment head moved over the surface of the skin. It is a passive treatment typically provided by a clinician over a number of treatment sessions.
There is moderate-quality evidence that therapeutic ultrasound has statistically significant effects on pain and physical function in people with knee OA. There is no randomised controlled trial (RCT) involving participants with hip OA, thus the evidence level for this population group was downgraded to low quality because of concerns about indirectness (Appendix 5 of the Guideline for the management of knee and hip osteoarthritis: Technical document). Although the evidence suggests moderate effect sizes and a low risk of harms for therapeutic ultrasound in people with knee OA, the working group noted that current evidence is restricted to short-term (two to eight weeks) follow-up only. The working group also expressed concern about whether benefits are sustained once treatment finished. The available evidence suggests that three to five treatment sessions per week are required for benefits. Given the large number of visits required to a health professional for a treatment modality that is passive, and the financial cost this may impose on an individual, the working group felt that therapeutic ultrasound should not be offered to people with knee and/or hip OA.
Generally, there is no evidence to suggest that ultrasound therapy is unsafe. In view of its mechanisms of action, ultrasound therapy is rather unlikely to cause serious adverse events, but active surveillance of harms with formal monitoring of potential adverse events is clearly desirable.
Did you know you can now log your CPD with a click of a button?
Administrative-report.pdf (PDF 2.76 MB)
Algorithm-Holistic-assessment-diagnosis-and-management-of-knee-and-hip-osteoarthritis.pdf (PDF 0.05 MB)
Guideline-for-the-management-of-knee-and-hip-osteoarthritis-2nd-ed-Appendix-1.pdf (PDF 0.04 MB)
Guideline-for-the-management-of-knee-and-hip-osteoarthritis-2nd-ed-Appendix-2.pdf (PDF 0.05 MB)
Implementation-plan.pdf (PDF 1.79 MB)
Public-consultation-summary.pdf (PDF 0.29 MB)
Technical-document.pdf (PDF 5.79 MB)
Donate to the RACGP Foundation today and influence the future of general practice